Mursla Bio Introduces AI Precision Medicine Platform Built on Organ-Specific EV Isolation from Blood
The Platform addresses a major gap in liquid biopsy and precision medicine: enabling non-invasive access to organ-specific molecular information from blood with high spatial and biological resolution. Mursla Bio's Platform is built on its ability to isolate and analyze EVs which are secreted by specific organs into the bloodstream. The Platform reduces non-target background by up to five orders of magnitude compared to standard bulk EV isolation and significantly improves data structure, enhancing prediction model generalization.
The pre-print presents the first multi-layered validation of hepatocyte EV isolation in humans, confirming liver origin through proteomic and nucleic acid markers. Key supporting proteomics data was generated in collaboration with Evotec International GmbH. Patient samples were provided by University College London, with Professor Brian Davidson, a global leader in liver disease surgery and clinical research, contributing as a co-author. The study shows that Mursla Bio's method yields robust, organ-specific multi-omics data using minimal blood volume, offering a novel scalable approach for biomarker and AI development.
Mursla Bio's Platform incorporates optimized multi-omics workflows, embedded AI pipelines, and IVD translation processes to convert complex biological signals into practical, regulatory-grade assays. These assays are deployable on standard commercial instruments using patented, PCR and ELISA-like steps designed for clinical adoption. The Platform also underpins the development of EvoLiver™, the Company's lead clinical program for liver cancer surveillance in cirrhotic patients. Built on multi-omics data from over 300 patients, EvoLiver achieved 86% sensitivity and 88% specificity on a locked, IVD-compatible assay for early-stage hepatocellular carcinoma detection², and has received Breakthrough Device Designation from the FDA³.
Pierre Arsène, Founder and CEO of Mursla Bio, said: "EVs are nature's native signal enrichment system for long-distance communication between cells and organs. Our platform harnesses this biology to non-invasively access organ-specific, multi-omics data from just a small blood sample. It produces structured, biologically labeled datasets that are optimized for AI and ready to support diagnostic translation. EvoLiver is our first proof point of real-world clinical impact, and we are now expanding access to the platform to advance our pipeline and enable partnerships across other disease areas.'
Mursla Bio is expanding its pipeline and collaborations, with additional organ programs underway in cardiometabolic, lung, and neurological indications. The Platform will support pharma development through dynamic patient stratification, therapeutic response monitoring, surrogate markers and molecular phenotyping across complex disease biology.
For further information on Mursla Bio's AI Precision Medicine Platform, please visit https://mursla.com/ai-precision-platform/.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
16 hours ago
- Business Upturn
Lithios Beverages Drives Excitement in NYC with Successful Sampling Events and Times Square Billboard
Photo Courtesy of Lithios Beverages NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) — Lithios Beverages, an innovator in functional drinks inspired by the energizing potential of lithium, just wrapped up a slate of in-store sampling events across Manhattan and Brooklyn, including at Fairway Gardens Kips Bay, Brooklyn Fair, and 2131 Broadway Street. Led by Alex and Tina Genzer, Lithios Beverages stands out with its unique fusion of flavor and function. Recent samplings saw enthusiastic crowds exploring Lithios Beverages' trio of standout flavors: Berry, Electric Lime, and Orange Mango. 'The feedback has been incredible. Everyone connects with different flavors, and the positive energy at our events was contagious,' said Tina Genzer. The spontaneous excitement around the upcoming launch of Brain Fuel+ Hydration Drink Mix was undeniable, with guests eagerly reserving their spots after learning about its breakthrough formula. Crafted with a mineral-rich base and enhanced by Max Catalyst™ for faster absorption, it delivers 71+ trace minerals from ConcenTrace®, essential electrolytes, Vitamin C, and B12—all in a clean, highly bioavailable format. Science-backed functional ingredients like GeniusPure® Alpha GPC and SalidroPure® Salidrosides support immunity, focus, mental clarity, and natural energy, while helping the body adapt to stress and combat fatigue. Consumers are invited to sign up online ahead of the official launch to receive 10% off their first order. Dustin Elliott, chief brand officer at NNB Nutrition, shared: 'Lithios Beverages captures what NNB stands for—real progress in human performance. GeniusPure® is the most concentrated, clinically researched Alpha GPC, shown to improve cognitive function with just one serving. And SalidroPure™ delivers 99% pure, naturally fermented salidrosides, offering a sustainable alternative to Rhodiola without compromising potency.' The interactive environment saw customers trying creative flavor combinations and brainstorming cocktail ideas, showing buzz building up for Lithios Beverages' next product line. ' The energy was remarkable. People started blending flavors, exchanging recipes, and already envisioning new ways to enjoy our Brain Fuel+ Hydration Drink Mix,' noted co-founder Alexander Genzer. 'Clearly, New Yorkers are looking for hydration that truly supports mind and body.' Lively testimonials continue to flood the company's Instagram (@drinklithiosbeverages). Lithios Beverages also recently made its Times Square debut with stunning billboard spots. This overwhelming support has prompted Fairway Markets to request more sampling events and secure additional inventory. Industry recognition is following suit. Lithios Beverages was spotlighted in GI's recent 'Companies to Watch' report, drawing attention to the broader growth of functional drinks inspired by the dynamic properties associated with lithium. The report, which highlights the functional beverage sector through 2033, can be accessed in the Press and Media area of the Lithios Beverages website. 'We're honored by the excitement and curiosity Lithios Beverages is generating,' said Tina Genzer. 'Just as lithium powers modern technology, Lithios Beverages energizes everyday wellness. Our upcoming Brain Fuel+ Hydration will go even further to meet today's needs for clarity, resilience, and refreshment.' Lithios Beverages is continuing in-store sampling across NYC throughout July, with more events planned for September. It has also opened a round for early-stage investors. For more information, visit or follow @drinklithiosbeverages on Instagram. Contact information:Tina GenzerLithios Beverages Website: [email protected]
Business Wire
20 hours ago
- Business Wire
Destiny Tech100 Inc. Reports Second Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--Destiny Tech100 Inc. (NYSE: DXYZ) today announced financial results for the quarter ended June 30, 2025. The fund reported a net asset value (NAV) of $6.92 per share of common stock, up from $6.31 per share at the end of the first quarter of 2025. As of June 30, 2025, Destiny Tech100's investment portfolio had an aggregate fair value of approximately $76.8 million, including short-term investments. The fund maintains positions in a variety of privately-held technology companies. Additional Information For more information about the Tech100 fund, Destiny XYZ Inc., the Fund's parent company, has made extensive resources available on its website. Prospective investors and the general public are encouraged to visit (in the Literature section) to receive the Fund's most recent annual report and other important information. About Destiny Tech100 Destiny Tech100 ('DXYZ' and 'Tech100'), is a publicly-listed registered closed-end fund that intends to invest in a portfolio of 100 of the top venture-backed private technology companies, providing everyday investors access to many of the world's most exciting private businesses. Destiny Tech100 Inc. is currently listed on the New York Stock Exchange under the ticker symbol 'DXYZ.' For a comprehensive list of holdings, visit the fund website at
Business Wire
21 hours ago
- Business Wire
Supermicro Announces Participation in Upcoming Investor Events
SAN JOSE, Calif.--(BUSINESS WIRE)-- Super Micro Computer, Inc. (Nasdaq: SMCI) ('Supermicro' or the 'Company'), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced its participation in the upcoming investor conferences: Event: Keybanc Tech Leadership Forum Date: August 11, 2025 Fireside Chat: 11:30am MT Location: Park City, UT Event: Citi Global TMT Conference Date: September 4, 2025 Fireside Chat: 9:30am ET Location: New York, NY Event: Goldman Sachs Communacopia + Technology Conference Date: September 8-9, 2025 1x1 meetings only Location: San Francisco, CA About Super Micro Computer, Inc. Supermicro (NASDAQ: SMCI) is a global leader in Application-Optimized Total IT Solutions. Founded and operating in San Jose, California, Supermicro is committed to delivering first-to-market innovation for Enterprise, Cloud, AI, and 5G Telco/Edge IT Infrastructure. We are a Total IT Solutions manufacturer with server, AI, storage, IoT, switch systems, software, and support services. Supermicro's motherboard, power, and chassis design expertise further enables our development and production, enabling next-generation innovation from cloud to edge for our global customers. Our products are designed and manufactured in-house (in the US, Taiwan, and the Netherlands), leveraging global operations for scale and efficiency and optimized to improve TCO and reduce environmental impact (Green Computing). The award-winning portfolio of Server Building Block Solutions® allows customers to optimize for their exact workload and application by selecting from a broad family of systems built from our flexible and reusable building blocks that support a comprehensive set of form factors, processors, memory, GPUs, storage, networking, power, and cooling solutions (air-conditioned, free air cooling or liquid cooling). Supermicro, Server Building Block Solution, and We Keep IT Green are trademarks and/or registered trademarks of Super Micro Computer, Inc.
